China

Home / China / Latest

Sinopharm applies for vaccine market approval

chinadaily.com.cn | Updated: 2020-11-25 14:29

Share

Share - WeChat

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. [Photo/Xinhua]

Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.

Photo

Journey to Dragon Tiger Mountain

Mist transforms Guizhou bridge into floating wonder

Amusement park featuring China's celebrated cartoon figures opens

World robot carnival kicks off in Wuhan

Wanshou Palace rises to reclaim cultural, commercial status

Explore Xinjiang: Children's colorful life

Latest

State Council News

China unveils new regulations on government data sharing

Exclusive

Children's Day: Let your dreams fly high

Smart container terminal operations in Chongqing

How barrier-free environment defines living

Newsmaker

Deaf locksmith's enthusiasm key to a happy life

Director devotes life to being 'mom' to orphans

Ten photos you don't wanna miss

Ten photos from across China: May 23 - 29

Special Coverage

The Real Xinjiang through a Thousand Voices

2025 NPC & CPPCC National Committee annual sessions

BACK TO THE TOP

English

中文

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349

About China Daily

Advertise on Site

Expat Employment

FOLLOW US